These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34018447)

  • 1. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
    Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
    Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis.
    Jangholi E; Tehran HA; Ghasemi A; Hoseinian M; Firoozi S; Ghodsi SM; Tamaddon M; Bereimipour A; Hadjighassem M
    Cancer Rep (Hoboken); 2024 Jul; 7(7):e2080. PubMed ID: 38967113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
    Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
    Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC12A5 as a novel potential biomarker of glioblastoma multiforme.
    Chen J; Wang H; Deng C; Fei M
    Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analysis and verification of molecular genetic targets for glioblastoma.
    Xue L; Liu H; Chen Y; Wei L; Hong J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Gene Expression Data-Driven Identification of Molecular Signatures, Prognostic Biomarkers, and Drug Targets for Glioblastoma.
    Alom MW; Jibon MDK; Faruqe MO; Rahman MS; Akter F; Ali A; Rahman MM
    Biomed Res Int; 2024; 2024():6810200. PubMed ID: 39184354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary glioblastoma transcriptome data analysis for screening survival-related genes.
    Yang Y; Yan R; Zhang L; Meng X; Sun W
    J Cell Biochem; 2020 Feb; 121(2):1901-1910. PubMed ID: 31633244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.